Biology of chronic myelogenous leukemia: is discordant maturation the primary defect?STRIFE, A; CLARKSON, B.Seminars in hematology. 1988, Vol 25, Num 1, pp 1-19, issn 0037-1963Article

CELL KILL KINETICS WITH HYDROXYUREA.YATAGANAS X; STRIFE A; PEREZ A et al.1976; MED. PEDIATR. ONCOL.; U.S.A.; DA. 1976; VOL. 2; NO 1; PP. 39-54; BIBL. 1 P. 1/2Article

THE KINETIC SIGNIFICANCE OF CEL SIZE. I. VARIATION OF CELL CYCLE PARAMETERS WITH SIZE MEASURED AT MITOSIS = IMPORTANCE CINETIQUE DU VOLUME DES CELLULES. I. VARIATION DES PARAMETRES DU CYCLE CELLULAIRE AVEC LE VOLUME MESURE A LA MITOSEYEN A; FRIED J; KITAHARA T et al.1975; EXPER. CELL RES.; U.S.A.; DA. 1975; VOL. 95; NO 2; PP. 295-302; BIBL. 15 REF.Article

MICROFLUORIMETRIC EVALUATION OF CELL KILL KINETICS WITH 1-BETA -D-ARABINOFURANOSYLCYTOSINEYATAGANAS X; STRIFE A; PEREZ A et al.1974; CANCER RES.; U.S.A.; DA. 1974; VOL. 34; NO 10; PP. 2795-2806; BIBL. 1 P. 1/2Article

ENRICHMENT OF HEMATOPOIETIC PROGENITOR CELLS (CFUC AND BFUE) FROM HUMAN PERIPHERAL BLOODWISNIEWSKI D; PLATSOUCAS C; STRIFE A et al.1982; EXP. HEMATOL.; ISSN 0301-472X; USA; DA. 1982; VOL. 10; NO 10; PP. 817-829; BIBL. 42 REF.Article

THE KINETIC SIGNIFICANCE OF CELL SIZE. II. SIZE DISTRIBUTIONS OF RESTING AND PROLIFERATING CELLS DURING INTERPHASE = IMPORTANCE CINETIQUE DU VOLUME DES CELLULES II. DISTRIBUTIONS EN VOLUME DES CELLULES AU REPOS ET EN PROLIFERATION AU COURS DE L'INTERPHASEYEN A; FRIED J; KITAHARA T et al.1975; EXPER. CELL RES.; U.S.A.; DA. 1975; VOL. 95; NO 2; PP. 303-310; BIBL. 17 REF.Article

Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatmentCLARKSON, B; STRIFE, A.Leukemia. 1993, Vol 7, Num 11, pp 1683-1721, issn 0887-6924Article

New understanding of the pathogenesis of CML : a prototype of early neoplasiaCLARKSON, B. D; STRIFE, A; WISNIEWSKI, D et al.Leukemia. 1997, Vol 11, Num 9, pp 1404-1428, issn 0887-6924Article

c-kit ligand stimulates tyrosine phosphorylation of the c-Cbl protein in human hematopoietic cellsWISNIEWSKI, D; STRIFE, A; CLARKSON, B et al.Leukemia. 1996, Vol 10, Num 9, pp 1436-1442, issn 0887-6924Article

Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patientsKONOPKA, J. B; CLARK, S; MCLAUGHLIN, J et al.Proceedings of the National Academy of Sciences of the United States of America. 1986, Vol 83, Num 11, pp 4049-4052, issn 0027-8424Article

Proliferation of human hematopoietic progenitors in long-term bone marrow cultures in gas-permeable plastic bags in enhanced by colony-stimulating factorsLEMOLI, R. M; TAFURI, A; STRIFE, A et al.Experimental hematology. 1992, Vol 20, Num 5, pp 569-575, issn 0301-472XArticle

Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factor IL-3, GM-CSF and G-CSF alone and in combinationLEMOLI, R. M; GULATI, S. C; STRIFE, A et al.Leukemia. 1991, Vol 5, Num 5, pp 386-391, issn 0887-6924Article

The effects of transforming growth factor β₃ on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral bloodSTRIFE, A; LAMBEK, C; PEREZ, A et al.Cancer research (Baltimore). 1991, Vol 51, Num 18, pp 4828-4836, issn 0008-5472Conference Paper

c-kit ligand stimulates tyrosine phosphorylation a similar pattern of phosphotyrosyl proteins in primary primitive normal hemtopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemiaWISNIEWSKI, D; STRIFE, A; BERMAN, E et al.Leukemia. 1996, Vol 10, Num 2, pp 229-237, issn 0887-6924Article

A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populationsWISNIEWSKI, D; STRIFE, A; WOJCIECHOWICZ, D et al.Leukemia. 1994, Vol 8, Num 4, pp 688-693, issn 0887-6924Conference Paper

Differences in the composition and in the efficiency of red cell production of normal and CML erythroid progenitor populations are highlighted by response to human c-kit ligandSTRIFE, A; PEREZ, A; LAMBEK, C et al.Leukemia research. 1993, Vol 17, Num 9, pp 799-807, issn 0145-2126Article

Monoclonal antibody YB5.B8 identifies the human c-kit protein productLERNER, N. B; NOCKA, K. H; COLE, S. R et al.Blood. 1991, Vol 77, Num 9, pp 1876-1883, issn 0006-4971Article

Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategiesCLARKSON, B; STRIFE, A; WISNIEWSKI, D et al.Leukemia. 2003, Vol 17, Num 7, pp 1211-1262, issn 0887-6924, 52 p.Article

Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210^BCR-ABLBERMAN, E; JHANWAR, S; MCBRIDE, M et al.Leukemia research. 2000, Vol 24, Num 4, pp 289-297, issn 0145-2126Article

TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitroLEMOLI, R. M; STRIFE, A; CLARKSON, B. D et al.Experimental hematology. 1992, Vol 20, Num 11, pp 1252-1256, issn 0301-472XArticle

Co-detection of chimeric BCR/ABL (target) and β-actin (control) messenger RNA in individual CFU-GM colonies derived from CML patients using the polymerase chain reactionWISNIEWSKI, D; STRIFE, A; CLARKSON, B et al.Leukemia research. 1991, Vol 15, Num 9, pp 867-874, issn 0145-2126Article

A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) Is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cellsWISNIEWSKI, D; STRIFE, A; SWENDEMAN, S et al.Blood. 1999, Vol 93, Num 8, pp 2707-2720, issn 0006-4971Article

Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligandSTRIFE, A; PEREZ, A; LAMBEK, C et al.Cancer research (Baltimore). 1993, Vol 53, Num 2, pp 401-409, issn 0008-5472Article

Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeadsSHIMAZAKI, C; WISNIEWSKI, D; SCHEINBERG, D. A et al.Blood. 1988, Vol 72, Num 4, pp 1248-1254, issn 0006-4971Article

Photoradiation models for the clinical ex vivo treatment of autologous bone marrow graftsATZPODIEN, J; GULATI, S. C; STRIFE, A et al.Blood. 1987, Vol 70, Num 2, pp 484-489, issn 0006-4971Article